These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1316430)

  • 1. Levodopa induced ON-OFF motor fluctuations in Parkinson's disease related to rhythmical masticatory jaw movements.
    Karlsson S; Persson M; Johnels B
    J Neurol Neurosurg Psychiatry; 1992 Apr; 55(4):304-7. PubMed ID: 1316430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Masticatory function and oral sensorimotor ability in Parkinson's disease: Levodopa on versus off periods.
    Rodrigues Ribeiro G; Heitor Campos C; Barbosa Câmara-Souza M; Fraga do Amaral C; Rodrigues Garcia RCM
    Spec Care Dentist; 2019 Mar; 39(2):77-83. PubMed ID: 30597591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jaw movement dysfunction related to Parkinson's disease and partially modified by levodopa.
    Robertson LT; Hammerstad JP
    J Neurol Neurosurg Psychiatry; 1996 Jan; 60(1):41-50. PubMed ID: 8558149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.
    Chase TN
    Drugs; 1998; 55 Suppl 1():1-9. PubMed ID: 9483164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal dopaminoceptive system changes and motor response complications in L-dopa-treated patients with advanced Parkinson's disease.
    Chase TN; Engber TM; Mouradian MM
    Adv Neurol; 1993; 60():181-5. PubMed ID: 8420133
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980.
    Bravi D; Davis TL; Mouradian MM; Chase TN
    Mov Disord; 1993 Apr; 8(2):195-7. PubMed ID: 8097280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.
    Mouradian MM; Juncos JL; Fabbrini G; Schlegel J; Bartko JJ; Chase TN
    Ann Neurol; 1988 Sep; 24(3):372-8. PubMed ID: 3228271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
    O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
    Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.
    Luquin MR; Scipioni O; Vaamonde J; Gershanik O; Obeso JA
    Mov Disord; 1992; 7(2):117-24. PubMed ID: 1350058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the biochemical pharmacology of extrapyramidal movement disorders.
    Klawans HL; Goetz C; Nausieda PA; Weiner WJ
    Adv Exp Med Biol; 1977; 90():21-47. PubMed ID: 145167
    [No Abstract]   [Full Text] [Related]  

  • 11. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease.
    McColl CD; Reardon KA; Shiff M; Kempster PA
    Mov Disord; 2002 Nov; 17(6):1227-34. PubMed ID: 12465061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part I.
    Fabbrini G; Mouradian MM; Juncos JL; Schlegel J; Mohr E; Chase TN
    Ann Neurol; 1988 Sep; 24(3):366-71. PubMed ID: 3228270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Problems of levodopa treatment.
    Horstink MW
    Clin Neurol Neurosurg; 1984; 86(3):196-206. PubMed ID: 6091967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Motor complications in patients with Parkinson disease treated with levodopa].
    Luquin MR; Obeso JA; Martínez-Lage JM
    Neurologia; 1989; 4(1):4-11. PubMed ID: 2631806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
    Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of striatal dopamine D2 receptors in advanced Parkinson's disease contributes to the development of motor fluctuation.
    Hwang WJ; Yao WJ; Wey SP; Shen LH; Ting G
    Eur Neurol; 2002; 47(2):113-7. PubMed ID: 11844900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
    de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
    Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Problems arising during chronic treatment with L-dopa for Parkinson's disease: changes in response to treatment.
    Caraceni TA; Girotti F; Giovannini P; Parati E
    J Neural Transm Suppl; 1986; 22():189-99. PubMed ID: 3537210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of response fluctuations in Parkinson's disease by ambulatory wrist activity monitoring.
    van Hilten JJ; Kabel JF; Middelkoop HA; Kramer CG; Kerkhof GA; Roos RA
    Acta Neurol Scand; 1993 Mar; 87(3):171-7. PubMed ID: 8475685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of programmed masticatory movements in unilateral MPTP-treated monkeys as a model of jaw movement abnormality in Parkinson's disease.
    Adachi K; Kobayashi M; Kawasaki T; Yokoyama C; Waddington JL; Sakagami H; Onoe H; Koshikawa N
    J Neural Transm (Vienna); 2012 Aug; 119(8):933-41. PubMed ID: 22350537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.